Elevance Health, Inc. (ELV)
(Real Time Quote from BATS)
$313.76 USD
-2.01 (-0.64%)
Updated Sep 19, 2025 03:45 PM ET
5-Strong Sell of 5 5
A Value F Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ELV 313.76 -2.01(-0.64%)
Will ELV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELV
CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount
Arista Networks and Elevance Health have been highlighted as Zacks Bull and Bear of the Day
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bear of the Day: Elevance Health (ELV)
New Strong Sell Stocks for September 15th
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
Other News for ELV
ELV Crossed Above 20 Day Moving Average on September 18
Tracking William Nygren's Harris Associates Portfolio - Q2 2025 Update
20 Day Moving Average Resistance appears for ELV after 0.49% move
Obamacare tax credits could expand budget deficit by $350B if extended, CBO says
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting